|
|
Дата |
|---|
| 29.10.2026 |
| 28.10.2026 |
| 27.10.2026 |
| 26.10.2026 |
| 23.10.2026 |
| 22.10.2026 |
| 21.10.2026 |
| 20.10.2026 |
| 19.10.2026 |
| 16.10.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
0.091
|
0.1094
|
0.229
|
0.141
|
0.23
|
0.1648
|
|
|
195 122.85
|
2 264.00
|
|
0.2101
|
0.23
|
0.2211
|
0.2023
|
0.25
|
0.2361
|
|
|
139 029.13
|
1 381.00
|
|
0.23
|
0.2455
|
0.2576
|
0.2403
|
0.2699
|
0.2525
|
|
|
130 169.95
|
1 475.00
|
|
0.2501
|
0.27
|
0.2629
|
0.2327
|
0.301599
|
0.275
|
|
|
164 625.83
|
2 038.00
|
|
0.235
|
0.279
|
0.26
|
0.2265
|
0.3156
|
0.2946
|
|
|
3 398 409.18
|
19 702.00
|
|
0.3214
|
0.38
|
0.53
|
0.4601
|
0.53
|
0.47
|
|
|
81 372.76
|
521.00
|
|
0.47
|
0.56
|
0.4995
|
0.4995
|
0.5445
|
0.518
|
|
|
46 135.45
|
510.00
|
|
0.479
|
0.5139
|
0.49
|
0.472
|
0.5798
|
0.515
|
|
|
112 382.12
|
1 376.00
|
|
0.48
|
0.551
|
0.6952
|
0.4615
|
0.6952
|
0.472
|
|
|
107 299.49
|
1 231.00
|
|
0.6941
|
0.8101
|
0.8122
|
0.6602
|
0.8122
|
0.6804
|
|
|
60 731.75
|
522.00
|
Lunai Bioworks, Inc., formerly Renovaro Inc., is focused on AI-powered biodefense, drug discovery and advanced diagnostics. The Company is engaged in harnessing advanced computational biology and AI/machine learning to accelerate drug discovery, diagnostics and strengthen biosecurity capabilities. From high-resolution phenotyping to predictive disease modeling, the Company is pioneering a new era of precision diagnostics-where early detection, patient stratification, and therapeutic targeting converge into a single, adaptive platform. These are designed to transform clinical decision-making, reduce time-to-treatment, and unlock previously inaccessible insights from biological data.
Its proprietary platforms in translational analytics, in vivo modeling, and machine vision-accelerating biomarker discovery and therapeutic development in precision neurology and infectious disease.
Показать все Скрыть